Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-3335-2026

Atellica CH Revised C-Reactive Protein (RCRP); Siemens Material Number (SMN): 11537223; Recall

Atellica CH Revised C-Reactive Protein (RCRP); Siemens Material Number (SMN): 11537223;

FDA recall Class II

Ongoing

FDA lists this Class II recall for Atellica CH Revised C-Reactive Protein (RCRP); Siemens Material Number (SMN): 11537223;. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-3335-2026
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Aug 17, 2026
FDA report date
Oct 7, 2026
Quantity in commerce
42940 units (3938 US, 39002 OUS)
Distribution
See key details
FDA cause
Under Investigation by firm

What is being recalled?

Atellica CH Revised C-Reactive Protein (RCRP); Siemens Material Number (SMN): 11537223;

Affected model & UDI checker

Search the exact identifiers published for Z-3335-2026.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
Not specifiedAtellica CH Revised C-Reactive Protein (RCRP); Siemens Material Number (SMN): 11537223;Check source notice00630414610887
FDA code information

Siemens Material Number (SMN): 11537223; UDI-DI: 00630414610887; Lot numbers: All lots;

View the original FDA recall notice

Why was this product recalled?

The potential for falsely elevated results.

These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.

What actions did Siemens Healthcare Diagnostics, Inc. take?

On August 17, 2026 Urgent Medical Device Correction letters were sent to customers. Customer actions: 1. Follow the instructions provided to set-up and calibrate the device. 2. Record the number of unused tests discarded in Step 3 on the Field Correction Effectiveness Check form for reimbursement or credit. 3. Review this letter with your Medical Director to determine the appropriate course of action, including for any previously generated results, if applicable. 4. Complete and return the Field Correction Effectiveness Check Form attached to this letter within 30 days. 5. Retain this letter with your laboratory records and forward this letter to those who may have received the affected product.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA classification recorded

  3. FDA notice posted

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology